Adriblastine and agranulocytosis Patient Reports February 10, 2012

Adriblastine Side Effects Report #5042978-1
Adriblastine side effect was reported by a Physician from FRANCE on June 13, 2006. Male patient, 37 years of age, was diagnosed with multiple myeloma  and was treated with Adriblastine. After drug was administered, patient experienced the following side effects: agranulocytosis. Adriblastine dosage: 50 MG/25 ML, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE PHOSPHATE, CIPROFLOXACIN, CEFTAZIDIME PENTAHYDRATE, AUGMENTIN, ARANESP. Patient died on 04/21/2006.

Adriblastine Side Effects Report #5451722-5
Adriblastine side effect was reported by a Health Professional from FRANCE on Sept 03, 2007. Male patient, 76 years of age, was diagnosed with lymphoma  and was treated with Adriblastine. After drug was administered, patient experienced the following side effects: agranulocytosis, aplasia. Adriblastine dosage: unknown. During the same period patient was treated with ENDOXAN, CORTANCYL, NEUPOGEN, ARANESP, PROPRANOLOL HYDROCHLORIDE, NEXIUM. Patient was hospitalized. Patient recovered.